You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Iodo-Willardiine

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Iodo-Willardiine?

Iodo-Willardiine is an investigational drug.

There have been 11 clinical trials for Iodo-Willardiine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 1999.

The most common disease conditions in clinical trials are Neoplasms, Amyloidosis, and Diabetes Mellitus. The leading clinical trial sponsors are National Cancer Institute (NCI), Institut National de la Santé Et de la Recherche Médicale, France, and Institute for Neurodegenerative Disorders.

Recent Clinical Trials for Iodo-Willardiine
Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]University of Texas Southwestern Medical CenterN/A
Imaging of Advanced Tumours Using [131]I-IAZAUniversity of AlbertaPhase 1/Phase 2
Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain MetastasesNational Cancer Institute (NCI)Phase 1

See all Iodo-Willardiine clinical trials

Clinical Trial Summary for Iodo-Willardiine

Top disease conditions for Iodo-Willardiine
Top clinical trial sponsors for Iodo-Willardiine

See all Iodo-Willardiine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.